FOI release

Requesting information regarding the licensing of Ditropan Tablets in the UK/EU

Case reference FOI2025/00387

Received 22 April 2025

Published 23 July 2025

Request

Requesting information regarding Ditropan 2.5 mg and 5 mg tablets. Were these approved Europe wide and via a centralized or a MRP and is or was Northern Ireland listed as an concerned member state.

Response

see attached

Documents

• FOI2025_00387 redacted for publication.pdf (97.5 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.